Literature DB >> 10387044

Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase.

C T Beuckmann1, M Aoyagi, I Okazaki, T Hiroike, H Toh, O Hayaishi, Y Urade.   

Abstract

Lipocalin-type prostaglandin D synthase is a major protein of the cerebrospinal fluid and was originally known as beta-trace. We investigated the binding ability of prostaglandin D synthase toward bile pigments, thyroid hormones, steroid hormones, and fatty acids in this present study. We found that the recombinant enzyme binds bile pigments and thyroid hormones, resulting in quenching of the intrinsic tryptophan fluorescence, the appearance of induced circular dichroism of the lipophilic ligands, and a red shift of the absorption spectra of bilirubin and biliverdin. The binding of prostaglandin D synthase to lipophilic ligands was also demonstrated by the resonant mirror technique and surface plasmon resonance detection. The dissociation constants were calculated to be 33 nM, 37 nM, 660 nM, 820 nM, and 2.08 microM for biliverdin, bilirubin, L-thyroxine, 3,3',5'-triiodo-L-thyronine, and 3,3', 5-triiodo-L-thyronine, respectively. Biliverdin and bilirubin underwent a shift in their absorption peaks from 375 to 380 nm and from 439 to 446 nm, respectively, after binding to prostaglandin D synthase. Bilirubin bound to the enzyme showed a bisignate CD spectrum with a (-) Cotton effect at 422 nm and a (+) Cotton effect at 472 nm, indicating a right-handed chirality. The ligands also inhibited prostaglandin D synthase activity noncompetitively in a concentration-dependent manner, with IC50 values between 3.9 and 10. 9 microM. Epididymal retinoic acid-binding protein and beta-lactoglobulin, two other lipocalin proteins that bind retinoids such as prostaglandin D synthase, did not show any significant interaction with bile pigments or thyroid hormones. These results show that prostaglandin D synthase binds small lipophilic ligands with a specificity distinct from that of other lipocalins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10387044     DOI: 10.1021/bi990261p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects.

Authors:  Shinrye Lee; Eunha Jang; Jong-Heon Kim; Jae-Hong Kim; Won-Ha Lee; Kyoungho Suk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.

Authors:  Takahisa Kanekiyo; Tadato Ban; Kosuke Aritake; Zhi-Li Huang; Wei-Min Qu; Issay Okazaki; Ikuko Mohri; Shigeo Murayama; Keiichi Ozono; Masako Taniike; Yuji Goto; Yoshihiro Urade
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

4.  L-type prostaglandin D synthase regulates the trafficking of the PGD2 DP1 receptor by interacting with the GTPase Rab4.

Authors:  Chantal Binda; Samuel Génier; Jade Degrandmaison; Samuel Picard; Louis Fréchette; Steve Jean; Eric Marsault; Jean-Luc Parent
Journal:  J Biol Chem       Date:  2019-10-01       Impact factor: 5.157

5.  An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production.

Authors:  Karine Mathurin; Maxime A Gallant; Pascale Germain; Hugues Allard-Chamard; Jessy Brisson; Christian Iorio-Morin; Artur de Brum Fernandes; Marc G Caron; Stéphane A Laporte; Jean-Luc Parent
Journal:  J Biol Chem       Date:  2010-11-26       Impact factor: 5.157

6.  Ligand binding complexes in lipocalins: Underestimation of the stoichiometry parameter (n).

Authors:  Ben J Glasgow; Adil R Abduragimov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-07-07       Impact factor: 3.036

7.  Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase.

Authors:  Sing Mei Lim; Dan Chen; Hsiangling Teo; Annette Roos; Anna Elisabet Jansson; Tomas Nyman; Lionel Trésaugues; Konstantin Pervushin; Pär Nordlund
Journal:  J Lipid Res       Date:  2013-03-22       Impact factor: 5.922

8.  Serum β-trace protein and risk of mortality in incident hemodialysis patients.

Authors:  Tariq Shafi; Rulan S Parekh; Bernard G Jaar; Laura C Plantinga; Pooja C Oberai; John H Eckfeldt; Andrew S Levey; Neil R Powe; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

9.  Structural basis of the catalytic mechanism operating in open-closed conformers of lipocalin type prostaglandin D synthase.

Authors:  Takashi Kumasaka; Kosuke Aritake; Hideo Ago; Daisuke Irikura; Toshiharu Tsurumura; Masaki Yamamoto; Masashi Miyano; Yoshihiro Urade; Osamu Hayaishi
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

10.  Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.

Authors:  Daisuke Irikura; Kosuke Aritake; Nanae Nagata; Toshihiko Maruyama; Shigeru Shimamoto; Yoshihiro Urade
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.